# Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma

Page: https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma
Text version: https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma.md
Podcast: [Neuro-Oncology: The Podcast](https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653)
Published: 2026-03-02T11:00:00+00:00
Episode link: https://soc-neuro-onc.libsyn.com/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma
Audio file: https://traffic.libsyn.com/secure/soc-neuro-onc/nop-118-authorinterview.mp3?dest-id=2339594
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma
Duration seconds: 1247

## Resource

Dr. Maya Graham interviews Dr. Lauren Schaff on her manuscript entitled "Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)," published in Neuro-Oncology in January 2026.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/author-interview-ibrutinib-for-newly-diagnosed-primary-cns-lymphoma.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.